Bio Rad Laboratories Inc (NYSE:BIO)
| 631.74 Delayed Data As of Jun 24 |  -0.16 / -0.03%Today’s Change | 425.43 Today|||52-Week Range 689.00 | +8.37% Year-to-Date |
Latest BIO News | Press Releases
| Gentex and Logitech Show High Profit, Low Debt Jun 21 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 631.90 |
| Today’s open | 626.23 |
| Day’s range | 626.23 - 633.15 |
| Volume | 3 |
| Average volume (3 months) | 157,104 |
| Market cap | $15.4B |
Data as of 3:59pm ET, 06/24/2021
Growth & Valuation
| Earnings growth (last year) | +116.97% |
| Earnings growth (this year) | +17.51% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +10.12% |
| P/E ratio | 4.7 |
| Price/Sales | 6.91 |
| Price/Book | 1.88 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PKIPerkinElmer Inc | -0.14 | -0.09% |
| QGENQiagen NV | +0.01 | +0.02% |
| BRKRBruker Corp | -0.25 | -0.34% |
| WATWaters Corp | -0.01 | -0.00% |
Data as of 4:15pm ET, 06/24/2021
Financials
| Next reporting date | August 5, 2021 |
| EPS forecast (this quarter) | $2.66 |
| Annual revenue (last year) | $2.5B |
| Annual profit (last year) | $3.8B |
| Net profit margin | 149.52% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Hercules, California |
Forecasts
